[1] Lee A W,Sze WM,Au JS,et al. Treatment results for nasopharyngeal carcinoma in the modern era: the Hong Kong experience. Int J Radiat Oncol Biol Phys,2005,61:1107-1116. [2] Maguire PD,Papagikos M,Hamann S,et al. Phase Ⅱ trial of hyperfractionated intensity-modulated radiation therapy and concurrent weekly cisplatin for Stage Ⅲ and Ⅳa head-and-neck cancer. Int J Radiat Oncol Biol Phys,2011,79:1081-1088. [3] Bachaud JM,David JM,Boussin G,et al. Combined postoperative radiotherapy and weekly cisplatin infusion for locally advanced squamous cell carcinoma of the head and neck: preliminary report of a randomized trial. Int J Radiat Oncol Biol Phys,1991,20:243-246. [4] Yao M,Dornfeld KJ,Buatti JM,et al. Intensity-modulated radiation treatment for head-and-neck squamous cell carcinoma—the university of Iowa experience. Int J Radiat Oncol Biol Phys,2005,63:410-421. [5] Pignon JP,le Maitre A,Maillard E,et al. Meta-analysis of chemotherapy in head and neck cancer(MACH-NC): an update on 93 randomised trials and 17,346 patients. Radiother Oncol,2009,92:4-14. [6] Traynor AM,Richards GM,Hartig GK,et al. Comprehensive IMRT plus weekly cisplatin for advanced head and neck cancer: the university of Wisconsin experience. Head Neck,2010,32:599-606.
2012, Vol. 21 
